CA 2721333A1
· 2009
[cited by applicant]
CN 108998451A
· 2018
[cited by applicant]
GenBank IL-18 mRNA Sequence Nov. 2023 version (Year: 2023).
[cited by examiner]
Gorski, S., Vogel, J. & Doudna, J., Nat Rev Mol Cell Biol 18, 215-228 (2017) (Year: 2017).
[cited by examiner]
O'Brien, et al., Aug. 3, 2018, Front Endocrinol (Lausanne), 9:402, p. 1-12; Fig. 1; p. 2, “Biogenesis of miRNAs” (Year: 2018).
[cited by examiner]
Lam et al. 2015. Molec. Ther. Nuc. Ac. 4:e252 (Year: 2015).
[cited by examiner]
Ying et al. 2008. Mol. Biotechnol. 38:257-268 (Year: 2008).
[cited by examiner]
Zhang et al. “Cytokines, inflammation, and pain.”
[cited by applicant]
WIPO translation of CN108998451 (2018).
[cited by applicant]
Asirvatham et al. “miRNA regulation of cytokine genes.” Cytokine 45.2 (2009): 58-69.
[cited by applicant]
Christensen et al. “Recombinant adeno-associated virus-mediated microRNA delivery into the postnatal mouse brain reveals a role for miR-134 in dendritogenesis in vivo.” Frontiers in neural circuits 3 (2010): 848.
[cited by applicant]
Bofill-De Ros et al. “Guidelines for the optimal design of miRNA-based shRNAs.” Methods 103 (2016): 157-166.
[cited by applicant]
Tritschler et al. “Concepts and limitations for learning developmental trajectories from single cell genomics.” Development 146.12 (2019): dev170506.
[cited by applicant]
Nature (2010. Gene Expression. Scitable. Available online at Nature.com) <https://www.nature.com/scitable/topicpage/gene-expression-14121669> (2010).
[cited by applicant]
Shang et al. “microRNAs in action: biogenesis, function and regulation.” Nature Reviews Genetics 24.12 (2023): 816-833.
[cited by applicant]
Agarwal et al. “Predicting effective microRNA target sites in mammalian mRNAs.” elife 4 (2015): e05005.
[cited by applicant]
Fayyad-Kazan et al. “Downregulation of microRNA-24 and-181 parallels the upregulation of IFN-γ secreted by activated human CD4 lymphocytes.” Human immunology 75.7 (2014): 677-685.
[cited by applicant]
Patton et al. “Biogenesis, delivery, and function of extracellular RNA.” Journal of extracellular vesicles 4.1 (2015): 27494.
[cited by applicant]
NCBI Search results for SEQ ID No. 5 2024.
[cited by applicant]
Ying et al. “The microRNA (miRNA): overview of the RNA genes that modulate gene function.” Molecular biotechnology 38 (2008): 257-268.
[cited by applicant]
Lam et al. “siRNA versus miRNA as therapeutics for gene silencing.” Molecular therapy Nucleic acids 4 (2015).
[cited by applicant]
Kondratov et al. “Direct head-to-head evaluation of recombinant adeno-associated viral vectors manufactured in human versus insect cells.” Molecular Therapy 25.12 (2017): 2661-2675.
[cited by applicant]
Wang et al. “Adeno-associated virus vector as a platform for gene therapy delivery”. Nat Rev Drug Discov. May 2019;18(5):358-378. (Year: 2019).
[cited by applicant]
Momin et al., 2021, Cells, 10, 3097, p. 1-21 (Year: 2021).
[cited by applicant]
“The Risks of miRNA Therapeutics: In a Drug Target Perspective” (Zhang et al.—2021).
[cited by applicant]
Van den Berg, et al., pp. 1-12, Molecular Therapy—Nucleic Acids, vol. 5, 2016 (Year: 2016).
[cited by applicant]
Denzler R et al. Impact of MicroRNA Levels, Target-Site Complementarity, and Cooperativity on Competing Endogenous RNA-Regulated Gene Expression. Mol Cell. Nov. 3, 2016;64(3):565-579. doi: 10.1016/j.molcel.2016.09.027 (…
[cited by applicant]
GenBank IL-1b gene Sequence (2023).
[cited by applicant]
Ahmadzadeh et al. “BRAF mutation in hairy cell leukemia.” Oncology reviews 8.2 (2014): 253.
[cited by applicant]